Search Results for "Benzodiazepine Multiple Sclerosis"

23:46 EDT 28th June 2017 | BioPortfolio

Matching Channels

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...

Systemic Sclerosis

Amyotrophic lateral sclerosis ALS

Diffuse mesangial sclerosis

B lymphocyte stimulator BlyS

Treatment of inflammatory and autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis and multiple sclerosis.

Matching News

Resetting the Immune System to Stop Multiple Sclerosis

A clinical trial led by Imperial College London has revealed the potential of a risky new therapy to stop the progression of multiple sclerosis. Worldwide, there are 2.3 million people with multiple s...

Medical News Today: Best multiple sclerosis blogs

Multiple sclerosis blogs are both helpful and inspirational for people affected by the disease. We have selected the 10 best multiple sclerosis blogs.

[Articles] Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study

More frequent use of health care in patients with multiple sclerosis than in controls in the 5 years before a first demyelinating event, according to health administrative data, suggests the existence...

A New Peptide Vaccine for Multiple Sclerosis Succeeds in Phase IIa

Apitope is developing therapeutic peptides to induce suppression of autoimmune responses towards self-antigens. Their recent phase IIa trial has revealed promising results for the treatment of multipl...

Ocrelizumab for Multiple Sclerosis

A Phase III trial of ocrelizumab in primary-progressive multiple sclerosis and two Phase III trials of ocrelizumab in relapsing-remitting multiple sclerosis have demonstrated efficacy with treatment.

Helius Medical Technologies Announces Publication of Multiple Sclerosis Pilot Study Results in Multiple Sclerosis Journal: Experimental, Translational and Clinical

Thursday, February 9th 2017 at 5:00pm UTC NEWTOWN, Pa.–(BUSINESS WIRE)– Helius Medical Technologies, Inc. (TSX: HSM, HSM.S, OTCQB: HSDT) (« Helius ») is pleased to anno...

Medication Discontinuation in Patients With Multiple Sclerosis: A Conversation With John R. Corboy, MD

The pros and cons of discontinuing disease-modifying therapies in multiple sclerosis.

Helius Medical Technologies Announces Publication Of Multiple Sclerosis Pilot Study Results In Multiple Sclerosis Journal:

  Life Sciences Jobs   ...

Matching PubMed Articles

A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry.

Primary progressive multiple sclerosis (PPMS) represents 10%-15% of all multiple sclerosis (MS) diagnoses. Information regarding socio-demographic and clinical characteristics of persons with PPMS is ...


Corrigendum to Ragheb, S et al. (2011). Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid Multiple Sclerosis Journal 17(07) 819-829. [DOI: 10.1177/1352458511398887].

Changes to the septo-fornical area might play a role in the pathogenesis of anxiety in multiple sclerosis.

Reports on the relationships between white matter lesion load (WMLL) and fatigue and anxiety in multiple sclerosis (MS) are inconsistent.

Temperature dependence of multiple sclerosis mortality rates in the United States.

It is well known that multiple sclerosis (MS) patients are very sensitive to heat events. However, how MS patients respond to the significant temperature difference between the high- and low-latitude ...

Hippocampal dysfunction is associated with memory impairment in multiple sclerosis: A volumetric and functional connectivity study.

Previous studies have suggested a relationship between neuroanatomical and neurofunctional hippocampal alterations and episodic memory impairments in multiple sclerosis (MS) patients.

Search Whole site using Google

Quick Search
Advertisement Advertisement